TATVA — Tatva Chintan Pharma Chem Cashflow Statement

0.000.00%

Last trade - 00:00

Basic MaterialsBalancedSmall CapNeutral

Annual cashflow statement for Tatva Chintan Pharma Chem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	C2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	476	607	1,041	448	436
Depreciation
Non-Cash Items	39	2.82	19.5	116	31.9
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-310	-480	-939	-382	257
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	253	197	204	278	980
Capital Expenditures	-482	-210	-892	-2,031	-1,285
Purchase of Fixed Assets
Other Investing Cash Flow Items	79.9	3.11	-1,076	1,020	79.8
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-402	-207	-1,968	-1,011	-1,205
Financing Cash Flow Items	-35.9	-42.7	2,032	-128	1,841
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	99.5	-47.1	2,350	378	305
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-49.2	-56.8	585	-357	79.4